Category:
Prophylactic Biological Products
CAS NO:
NA
Standard:
In-house Standards,
Inositol composite tablets are solid dosage forms containing myo-inositol and its stereoisomers, manufactured via direct compression or granulation. The primary active component is C6H12O6 (CAS: 87-89-8), often blended with choline bitartrate to enhance bioavailability for metabolic support.
Store in cool, dry conditions below 25°C away from light. Clinical use requires monitoring for gastrointestinal distress; avoid high doses in patients with specific renal impairments without medical supervision.